Hepatoprotective Effect of Syringic Acid and Vanillic Acid on CCl 4 -Induced Liver Injury
The mycelia of the edible mushroom Lentinula edodes can be cultured in solid medium containing lignin, and the hot-water extracts (L.E.M.) is commercially available as a nutritional supplement. During the cultivation, phenolic compounds, such as syringic acid and vanillic acid, were produced by lignin-degrading peroxidase secreted from L. edodes mycelia. Since these compounds have radical scavenging activity, we examined their protective effect on oxidative stress in mice with CCl 4 -induced liver injury. We examined the hepatoprotective effect of syringic acid and vanillic acid on CCl 4 -induced chronic liver injury in mice. The injection of CCl 4 into the peritoneal cavity caused an increase in the serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. The intravenous administration of syringic acid and vanillic acid significantly decreased the levels of the transaminases. Four weeks of CCl 4 treatment caused a sufficiently excessive deposition of collagen fibrils. An examination of Azan-stained liver sections revealed that syringic acid and vanillic acid obviously suppressed collagen accumulation and significantly decreased the hepatic hydroxyproline content, which is the quantitative marker of fibrosis. Both of these compounds inhibited the activation of cultured hepatic stellate cells, which play a central role in liver fibrogenesis, and maintained hepatocyte viability. These data suggest that the administration of syringic acid and vanillic acid could suppress hepatic fibrosis in chronic liver injury.
of Pharmaceutical Sciences. The experimental protocol was submitted to the Committee on the Guidelines for Animal Experiments in Graduate School of Pharmaceutical Sciences, and the experiments were conducted after gaining the approval. Mice in the chronic liver injury model received intraperitoneal injections of CCl 4 (0.5 ml/kg body weight) and intravenously administered L.E.M., syringic acid, or vanillic acid (10 mg/kg body weight) twice a week for 4 weeks. Twenty-four hours after the L.E.M., syringic acid, or vanillic acid injection, the mice were anesthetized. Then, blood samples were collected to determine the transaminase activity, and the livers were excised for Azan staining and determination of hydroxyproline and malondialdehyde.
Assays Serum AST and ALT levels were measured by using an assay kit (Transaminase C-II, WAKO, Osaka, Japan).
Histological Analysis Liver specimens were fixed in 4% paraformaldehyde and embedded in paraffin. Sections were cut from the tissue blocks and mounted on slides. Azan staining was then performed to evaluate the extent of liver fibrosis.
Measurement of Hydroxyproline Content Hepatic hydroxyproline content was measured by using Kivirikko's method 10) with some modifications. Briefly, liver tissue (50 mg) was hydrolyzed with 6 mol/l HCl at 110°C for 24 h in a glass test tube. After centrifugation at 3000 rpm for 10 min, 2 ml of the supernatant was neutralized with 8 N KOH. Two grams of KCl and 1 ml of 0.5 mol/l borate buffer were then added to the neutralized supernatant, followed by a 15-min incubation at room temperature and then a 15-min incubation at 0°C. Freshly prepared chloramine-T solution was then added, and the sample was incubated at 0°C for 1 h, followed by the addition of 2 ml of 3.6 mol/l sodium thiosulfate. The samples were incubated at 120°C for 30 min. Then, 3 ml of toluene was added, and the samples were incubated for 20 min at room temperature. After centrifugation at 2000 rpm for 5 min, 2 ml of the supernatant was added to 0.8 ml buffer containing Ehrlich's reagent and incubated for 30 min at room temperature. The samples were then transferred to a plastic tube, and the absorbance was measured at 560 nm. The hydroxyproline content was expressed as micrograms of hydroxyproline per gram of liver.
Measurement of Malondialdehyde Lyophilized liver tissue (25 mg) was boiled for 30 min in a solution containing 250 ml of 1.15% KCl, 150 ml of 1% H 3 PO 4 , and 500 ml of 0.67% thiobarbituric acid. Two milliliters of n-butanol was added to the ice-chilled sample, and then the sample was stirred for 30 min. After centrifugation at 3000ϫg for 10 min, the upper n-butanol phase was collected, and the amount of malondialdehyde was colorimetrically determined at 535 and 520 nm.
Isolation and Culture of Hepatic Stellate Cells Hepatic stellate cells (HSCs) were isolated from 10-week-old male Sprague-Dawley rats by digesting the liver with Pronase-E (Merck Darmstadt, Germany) and collagenase type I (WAKO Pure Chemicals Co., Osaka, Japan) as previously described.
11) Isolated HSCs were seeded at a density of 2ϫ10 5 cells/cm 2 onto 24-well polystyrene culture plates (Asahi Techno Glass, Funabashi, Chiba, Japan) to observe the morphology and analyze fibrosis-related gene expression. Cells were cultured in Dulbecco's modified Eagle's medium (Sigma, St. Louis, MO, U.S.A.) supplemented with 10% fetal bovine serum.
Isolation and Culture of Hepatocytes Hepatocytes were isolated from male BALB/c mice by perfusing the liver with collagenase, according to the method of Seglen.
12) Cells were seeded at a density of 1ϫ10 5 cells/cm 2 into multi-well culture plates pre-coated with collagen type I (Asahi Techno Glass, Funabashi, Chiba, Japan). The basal medium consisted of 50 U/ml penicillin G, 50 mg/ml streptomycin (ICN Biochemicals, Inc., Costa Mesa, CA, U.S.A.), 1 mM insulin, 1 mM dexamethasone (WAKO Pure Chemicals Co., Osaka, Japan), and 10% fetal bovine serum in William's medium E (MP Biomedicals, Inc., Kayserberg, France). Six hours after the cells were seeded, the basal medium was replaced with medium containing L.E.M., syringic acid, or vanillic acid at a final concentration of 1.0 mg/ml without insulin and dexamethasone. Cells were then cultured for 24-48 h, and viable cells were counted after trypan blue staining.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) The HSCs were cultured for 7 d and the total RNA was extracted using High Pure RNA Isolation Kit (Roche, Mannheim, Germany). The gene expression of collagen 1 a(I) was analyzed using the following primers: forward 5Ј-TGCCGTGACCTCAAGATGTG-3Ј and reverse 5Ј-CAC-AAGCGTGCTGTAGGTGA-3Ј. The gene expression of a smooth muscle actin (a-SMA) was analyzed using the following primers: forward 5Ј-CCGAGATCTCACCGAC-TACC-3Ј and reverse 5Ј-TCCAGAGCGACATAGCACAG-3Ј. The gene expression of b-actin was analyzed using the following primers: forward 5Ј-CCCAGAGCAAGAGAGGC-ATC-3Ј and reverse 5Ј-CTCAGGAGGAGCAATGATCT-3Ј.
The RT-PCR was examined using RNA PDR Kit (TaKaRa, Kyoto, Japan).
Statistical Analysis The data were analyzed for statistical significance by using Student's t-test and Dunnett's test.
RESULTS

Effect on CCl 4 -Induced Chronic Liver Injury
We examined the hepatoprotective effect of syringic acid and vanillic acid on CCl 4 -induced chronic liver injury in mice. As shown in Fig. 2 , after 4 weeks of CCl 4 treatment, the activities of blood AST and ALT increased 30-fold and 127-fold, respectively, compared with controls. The intravenous administration of syringic acid or vanillic acid significantly decreased the activities of AST and ALT. These results suggest that syringic acid and vanillic acid suppress the hepatic inflammation caused by repeated CCl 4 treatments. We also examined the effect of syringic acid and vanillic acid on liver fibrogenesis. Figure 3 shows typical Azan staining results, in which fibrous materials are stained blue. In the controls (Fig.  3A) , hardly any blue staining was observed in the pericentral area. In contrast, the livers injured by chronic CCl 4 treatment displayed a considerable accumulation of fibrous materials (Fig. 3B) . CCl 4 treatment for 4 weeks caused an excessive deposition of collagen fibrils that was sufficient for the evaluation of the antifibrogenic effect of syringic acid and vanillic acid. Based on the results of Azan staining, the syringic acid and vanillic acid treatments obviously suppressed collagen accumulation (Figs. 3D, E) . To quantitatively evaluate the effect of syringic acid and vanillic acid on fibrogenesis, we measured the hepatic hydroxyproline content, which parallels the extent of fibrosis. After 4 weeks of CCl 4 treatment, the hepatic hydroxyproline content increased 4.6-fold as compared with the controls (Fig. 4) . The intravenous administration of syringic acid or vanillic acid significantly decreased the hepatic hydroxyproline content. These data suggest that syringic acid and vanillic acid can suppress hepatic fibrosis in chronic liver injury. Next, we measured the amount of malondialdehyde in the liver samples as a marker of oxidative stress. The malondialdehyde content was drastically increased after 4 weeks of CCl 4 treatment, but the intravenous administration of syringic acid or vanillic acid significantly decreased the malondialdehyde content to an almost normal level (Fig. 5) . The protective effects of syringic acid and vanillic acid were almost comparable to that of L.E.M. (Figs. 
2-5).
In Vitro Effect on HSC Activation and Hepatocyte Viability We examined the direct effect of syringic acid and vanillic acid on the activation of HSCs, which play a central role in liver fibrogenesis, using the monolayer culture. HSCs are activated during the monolayer culture to transform into proliferating myofibroblast-like cells. As shown in Fig. 6A , HSCs were activated after 7 d of culture to be fibroblastic cell-type. The addition of syringic acid or vanillic acid dosedependently suppressed the activation (Fig. 6B) . HSCs maintained their quiescent state by the addition of more than 0.5 mg/ml of the respective compound. Next, the effect of syringic acid and vanillic acid on gene expression of Type I collagen and a-SMA, which are markers of activated HSCs, was examined. HSCs were cultured for 7 d in the presence or absence of syringic acid or vanillic acid, and the gene expression was analysed by RT-PCR. As shown in Fig. 7 , syringic acid and vanillic acid remarkably suppressed the expression of collagen and a-SMA genes, indicating that the phenolic compounds directly act on HSCs and suppress the activation to maintain the quiescent state. We then examined the effect of the compounds on liver parenchymal hepatocytes using the primary culture (Fig. 8) . Hepatocytes were isolated and cultured in the presence or absence of syringic acid or vanillic acid. After 24 h of culture, viable cells were counted using trypan blue exclusion test. The addition of syringic acid or vanillic acid significantly maintained viability of cultured hepatocytes. These results suggested that syringic acid or vanillic acid might suppress liver fibrogenesis and inflammation by inhibiting HSC activation and protecting hepatocytes, respectively in chronically liver injured mice.
DISCUSSION
The physiological functions of plant-derived phenolic compounds have been extensively reported. 7, 13, 14) Syringic acid and vanillic acid possess antimicrobial, anti-cancer, and anti-DNA oxidation properties. [15] [16] [17] We recently found that syringic acid and vanillic acid could act as immunomodulators in mice with ConA-induced liver injury. 8) In the present study, we show that syringic acid and vanillic acid have protective effects in mice with CCl 4 -induced liver injury. Both phenolic compounds dramatically suppressed liver fibrogenesis in the chronic CCl 4 -treatment model. When these phenolics are orally administered to hamsters, they are adsorbed and appear in the blood within 40 min. 18) Although these compounds are intravenously administered in the present study, oral administration could also elicit the hepatoprotective effect. The syringic acid and vanillic acid contents in L.E.M. are 450 and 378 mg/g, respectively. Thus, the contents are relatively small, but these compounds are commercially available at low prices. Therefore, syringic acid and vanillic acid might be promising oral agents for the prevention of liver disease.
We evaluated the hepatoprotective effect of phenolic compounds in mice with CCl 4 -induced liver injury. After intravenous administration, CCl 4 is introduced into the liver, where it is toxic to hepatocytes. Cytochrome P-450 in the endoplasmic reticulum of hepatocytes catalyzes the dehalogenation to produce an unstable complex trichloromethyl radical, 19) resulting in the extensive necrosis of hepatocytes that leads to liver inflammation. In the present study, the transaminase level in the serum was drastically increased by CCl 4 treatment. Generation of ROS degrade polyunsaturated lipids to form malondialdehyde, which is a marker of oxidative stress. The chronic CCl 4 treatment significantly increased the malondialdehyde content of the liver. Syringic acid and vanillic acid clearly suppressed the transaminase and malondialdehyde levels in CCl 4 -treated mice. Since both of these compounds have 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity, 8) the suppression of ROS generation appears to be responsible for the hepatoprotective effect. Moreover, the CCl 4 -induced liver fibrogenesis was suppressed by the administration of syringic acid and vanillic acid. The activation of HSCs is responsible for the development of liver fibrosis. 20, 21) During liver injury with persistent inflammation, HSCs are activated to differentiate into proliferating myofibroblast-like cells and overproduce extracellular matrix, leading to fibrogenesis. Since HSCs are activated spontaneously during cell culture, 22) we examined the effect of syringic acid and vanillic acid on the activation of primary cell cultures of rat HSCs. Both of these compounds clearly inhibited the change from spherical to spindle shape and the expression of a-smooth muscle actin and collagen Type Ia genes, which are the markers of HSC activation. We also 986 Vol. 33, No. 6 Freshly isolated hepatocytes were cultured for 24 h in the absence or presence of 1.0 mg/ml syringic acid or vanillic acid. Viability was measured by trypan blue exclusion test. The data were analyzed by Dunnett's method ( * pϽ0.05, as compared to control).
examined the effect of syringic acid and vanillic acid on the maintenance of hepatocyte viability in vitro. Both of these compounds significantly maintained the viability of primary cell cultures of hepatocytes. Thus, syringic acid and vanillic acid could directly exert a physiological effect on hepatocytes and HSCs. Both phenolic compounds might affect CCl 4 metabolism to inhibit the generation of cytotoxic trichloromethyl radical in the liver. However, the direct effects of syringic acid and vanillic acid on HSCs and hepatocytes were shown in this study, and the protective effect was also shown in ConA-induced liver injured mice in our previous study. 8) Moreover, these phenolic compounds have strong radical scavenging activity. These results suggest that during the repeated treatment of CCl 4 , these compounds could protect hepatocytes and HSCs from CCl 4 -induced oxidative stress to suppress liver inflammation and fibrogenesis.
The hot-water extracts from cultured mycelia of L. edodes have versatile physiological effects and might contain promising seed compounds for pharmaceutical development. We have shown that syringic acid and vanillic acid have anti-oxidative and immunomodulating activities. In addition to these phenolics, L.E.M. could contain novel compounds with pharmaceutical potential. We are currently trying to isolate bioactive components from L.E.M.
